Nantahala Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79M | Sell |
353,982
-433,758
| -55% | -$5.87M | 0.19% | 79 |
|
|
2025
Q1 | $12.5M | Buy |
787,740
+155,234
| +25% | +$2.47M | 0.5% | 25 |
|
|
2024
Q4 | $7.79M | Hold |
632,506
| – | – | 0.33% | 48 |
|
|
2024
Q3 | $7.66M | Buy |
632,506
+100,000
| +19% | +$1.21M | 0.39% | 43 |
|
|
2024
Q2 | $6.23M | Buy |
532,506
+200,000
| +60% | +$2.34M | 0.36% | 45 |
|
|
2024
Q1 | $4.29M | Buy |
+332,506
| New | +$4.29M | 0.25% | 60 |
|